Skip to contentORBIMED CAPITAL LLC — Arcutis Biotherapeutics, Inc. insider: 66 transactions · InsiderLensORBIMED CAPITAL LLC
- Director at DOV PHARMACEUTICAL INC · on record since May 18, 2006
- Director at GIVEN IMAGING LTD · on record since May 26, 2006
- 10% owner at GIVEN IMAGING LTD · on record since May 26, 2006
- Director at MEMORY PHARMACEUTICALS CORP · on record since Apr 7, 2004
- FN4 at MEMORY PHARMACEUTICALS CORP · on record since Apr 7, 2004
- 10% owner at CRYOCOR INC · on record since Jun 19, 2007
- 10% owner at INSITUFORM TECHNOLOGIES INC · on record since May 17, 2004
- 10% owner at DOV PHARMACEUTICAL INC · on record since Jul 16, 2003
- 10% owner at ORTHOVITA INC · on record since Sep 4, 2003
- 10% owner at ChemoCentryx, Inc. · on record since Feb 15, 2012
- Director at Prelude Therapeutics Inc · on record since Apr 23, 2026
- 10% owner at Prelude Therapeutics Inc · on record since Apr 23, 2026
- 10% owner at LIFECELL CORP · on record since Dec 30, 2003
- Director at Alector, Inc. · on record since Feb 11, 2019
- 10% owner at Alector, Inc. · on record since Feb 11, 2019
- Director at ProNAi Therapeutics Inc · on record since Nov 26, 2019
- 10% owner at ProNAi Therapeutics Inc · on record since Nov 26, 2019
- Director at Arcutis Biotherapeutics, Inc. · on record since Jan 30, 2020
- 10% owner at Arcutis Biotherapeutics, Inc. · on record since Jan 30, 2020
- Director at Repare Therapeutics Inc. · on record since Jun 25, 2020
- Director at PMV Pharmaceuticals, Inc. · on record since Sep 29, 2020
- 10% owner at PMV Pharmaceuticals, Inc. · on record since Sep 29, 2020
- Director at Fusion Pharmaceuticals Inc. · on record since Jul 2, 2020
- Director at Kinnate Biopharma Inc. · on record since Dec 9, 2020
- 10% owner at Kinnate Biopharma Inc. · on record since Dec 9, 2020
- Director at ARS Pharmaceuticals, Inc. · on record since Dec 8, 2020
- 10% owner at ARS Pharmaceuticals, Inc. · on record since Dec 8, 2020
- Director at Decibel Therapeutics, Inc. · on record since Feb 19, 2021
- 10% owner at Decibel Therapeutics, Inc. · on record since Feb 19, 2021
- Director at ORPHAN MEDICAL INC · on record since May 6, 2005
- Director at 11 GOOD ENERGY INC · on record since Jul 16, 2021
- 10% owner at 11 GOOD ENERGY INC · on record since Jul 16, 2021
- Director at CRYOCOR INC · on record since Aug 22, 2005
Insider trading activity of ORBIMED CAPITAL LLC
- Transactions on record
- 66
- since Jan 14, 2004
- Open-market buys
- 8
- $54.8M
- Open-market sells
- 26
- $39.4M
- Companies traded
- 9
- last filing Aug 28, 2024
Figures computed from official regulatory filings — methodology.
Companies where ORBIMED CAPITAL LLC has traded
- ARS Pharmaceuticals, Inc.13 tx · $37.6M · Aug 28, 2024
- Prelude Therapeutics Inc1 tx · $5M · May 24, 2023
- ProNAi Therapeutics Inc6 tx · $108.1M · Jul 1, 2022
- Arcutis Biotherapeutics, Inc.14 tx · $27.7M · Apr 8, 2022
- Repare Therapeutics Inc.12 tx · $1.2M · Aug 30, 2021
- Kinnate Biopharma Inc.12 tx · Dec 9, 2020
- Fusion Pharmaceuticals Inc.4 tx · $15.3M · Jul 2, 2020
- Alector, Inc.3 tx · $7.4M · Jan 13, 2020
- ORTHOVITA INC1 tx · Jan 14, 2004
Track record of ORBIMED CAPITAL LLC
Statistical track record
Free- Open-market buys
- 8
- Last buy
- May 22, 2023
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of ORBIMED CAPITAL LLC
Co-insiders of ORBIMED CAPITAL LLC
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Thompson Peter AARS Pharmaceuticals, Inc. +3
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Aug 28, 2024 | Sell | -83,695 | 13.00 USD | $1.1M | SEC |
| Aug 23, 2024 | Sell | -69,500 | 13.03 USD | $905.6K | SEC |
| Aug 23, 2024 | Sell | -394,400 | 13.52 USD | $5.3M | SEC |
| Aug 23, 2024 | Sell | -391,482 | 12.94 USD | $5.1M | SEC |
| Aug 23, 2024 | Sell | -13,300 | 14.61 USD | $194.3K | SEC |
| May 24, 2023 | Buy | 869,565 | 5.75 USD | $5M | SEC |
| Jul 1, 2022 | Other | -226,704 | 55.00 USD | $12.5M | SEC |
| Jul 1, 2022 | OtherD | -170,437 | 0.00 USD | $0 | SEC |
| Jul 1, 2022 | OtherD | -170,437 | 0.00 USD | $0 | SEC |
| Jul 1, 2022 | OtherD | -1,136,250 | 0.00 USD | $0 | SEC |
| Jul 1, 2022 | Other | -226,704 | 55.00 USD | $12.5M | SEC |
| Jul 1, 2022 | Other | -1,511,362 | 55.00 USD | $83.1M | SEC |
| Apr 8, 2022 | Sell | -97,200 | 20.71 USD | $2M | SEC |
| Apr 8, 2022 | Sell | -167,800 | 20.66 USD | $3.5M | SEC |
| Apr 8, 2022 | Sell | -177,196 | 20.66 USD | $3.7M | SEC |
| Apr 8, 2022 | Sell | -102,800 | 20.71 USD | $2.1M | SEC |
| Apr 8, 2022 | Sell | -162,000 | 20.69 USD | $3.4M | SEC |
| Apr 8, 2022 | Sell | -171,204 | 20.69 USD | $3.5M | SEC |
| Aug 30, 2021 | Sell | -6,884 | 33.94 USD | $233.6K | SEC |
| Aug 30, 2021 | Sell | -4,157 | 34.52 USD | $143.5K | SEC |
| Aug 30, 2021 | Sell | -197 | 33.92 USD | $6.7K | SEC |
| Aug 30, 2021 | Sell | -6,500 | 33.92 USD | $220.5K | SEC |
| Aug 30, 2021 | Sell | -209 | 33.94 USD | $7.1K | SEC |
| Aug 30, 2021 | Sell | -126 | 34.52 USD | $4.3K | SEC |
| Aug 25, 2021 | Sell | -119 | 34.07 USD | $4.1K | SEC |